About 19.6M results
Open links in new tab
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for …
US FDA approves Pfizer's drug for rare bleeding disorder
Pfizer’s TALZENNA ® in Combination with XTANDI - Business Wire
Pfizer’s Hympavzi Approved for Treatment of Certain Types of …
Press Releases - Pfizer
Pfizer chief Albert Bourla to meet activist investor Starboard
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Pfizer wins FDA nod for hemophilia B drug that will be first once ...
Pfizer to Showcase Scientific Advancements in Respiratory and …
Pfizer rolls out another cost-cutting program, sets $1.5 billion …